“When AAPL launched the Apple Watch in 2015, many analysts were predicting big numbers. Some expected Apple Watch sales for the first year could top 40 million. Apple never released official figures, but industry estimates put the actual number at 12 million,” Moon writes. “That’s better than anyone else selling a smartwatch (by a long shot), but not the kind of numbers to represent a meaningful revenue boost for AAPL.”
“The FDA just announced its new Digital Health Innovation Plan, and it could change everything. Noting that digital technologies used in consumer devices ‘have the power to transform health care,’ the agency is trying to streamline the process needed for FDA approval,” Moon writes. “In short, being able to avoid the current FDA certification and gaining medical monitoring capabilities could see the potential market for AAPL explode, with Apple Watch sales taking off.”
Read more in the full article here.
MacDailyNews Take: If Apple achieves the holy grail for treating diabetes, non-invasive continuous glucose monitoring, Apple Watch would instantly become the essential device for hundreds of millions of people with diabetes.
According to the International Diabetes Federation:
Apple appears to be working on blood glucose monitoring as a way to address Type 2 Diabetes – May 22, 2017
Apple reportedly working on incorporating blood glucose sensor into Apple Watch – May 15, 2017
Apple secret team reportedly working holy grail for treating diabetes; initially envisioned by Steve Jobs – April 12, 2017
Apple patent details Apple Watch smart bands – January 24, 2017
Emails between Apple and FDA hint at future plans – December 1, 2016
Analyst: Apple smartbands are a part of the Apple Watch’s future – April 8, 2016
Apple patent application hints at Apple Watch ‘Smartbands’ utilizing hidden 6-pin data connector – February 20, 2016
Why Apple’s iWatch won’t measure glucose levels – February 26, 2014